MedPath

Comparison of chemotherapy before and after definitive chemotherapy-radiotherapy with definitive chemotherapy-radiotherapy alone in patients with advanced cervical cancer

Phase 2
Conditions
Cancer of cervix.
Malignant neoplasm of endocervix
C53.0
Registration Number
IRCT20211011052730N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
35
Inclusion Criteria

Patients with advanced cervical cancer (FIGO Ib3-II-III-IVA)

Exclusion Criteria

Previous treatment with neoadjuvant chemotherapy
History of previous surgical treatment
History of radiotherapy in the pelvis and abdomen

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease free survival. Timepoint: One year and two year after intervention. Method of measurement: Physical exam and pelvic MRI.;Improved treatment response. Timepoint: One year and two year after intervention. Method of measurement: Physical exam and pelvic MRI.;Reduction of radiation therapy-related side effects. Timepoint: One year and two year after intervention. Method of measurement: History and Physical exam and pelvic MRI.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath